Hepatic Encephalopathy clinical trials at UCSF
1 research study open to eligible people
Hepatic encephalopathy happens when liver disease affects the brain. UCSF is conducting trials to explore different treatments, like immunosuppressive therapy for children. These trials are important for better understanding and treating this condition.
TReatment for ImmUne Mediated PathopHysiology
open to eligible people ages 1-18
TReatment for ImmUne Mediated PathopHysiology (TRIUMPH) is a multi-center, three arm, randomized, controlled trial of immunosuppressive therapy for children with acute liver failure. The study will determine if suppressing inflammatory responses with either corticosteroids or equine anti-thymocyte globulin therapy improves survival for children with this rare, life-threatening condition.
San Francisco, California and other locations
Last updated: